Merrimack Pharmaceuticals Inc

NASDAQ:MACK   4:00:00 PM EDT
14.73
+0.02 (+0.14%)
4:20:01 PM EDT: $14.73 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Merrimack Pharmaceuticals Inc Stock, NASDAQ:MACK

One Broadway, 14th Floor, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.720.8606
Number of Employees:
http://www.merrimackpharma.com

Description

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.